Comparison of SP TFL and Ho:YAG for RIRS Using 145 µm and 200 µm Fibers
NCT ID: NCT04346485
Last Updated: 2021-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
105 participants
INTERVENTIONAL
2020-03-13
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* decreasing surgery time and laser-on time due to possibility of 4.3 fold ablation efficacy increase, which has been shown by Andreeva et al.;
* increasing the flexible ureteroscope tip deflection lower pole stones availability;
* decreased risk of complications and a better irrigation and visualization due to better irrigation with smaller fiber;
* increasing of lithotripsy efficacy and laser beam density by lowering of beam focal spot due to using of lesser fiber diameter
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SP TLF Versus Ho:YAG Laser
NCT05048706
Comparing Super Pulse Fiber Thulium Laser and Holmium Laser for Ureteral Stone Fragmentation During Ureteroscopy
NCT06667557
Super-Pulsed Thulium Fiber Laser Versus Holmium:YAG Laser in Retrograde Intrarenal Surgery for Upper Ureteral and Renal Stones
NCT07012941
Thulium vs. Hol:YAG Laser
NCT05808257
to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy
NCT05218057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A 10 Fr urethral catheter can be placed in the bladder for the drainage of the bladder during the operation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SP TFL RIRS with 145 mcm fiber
Superpulse thulium fiber laser RIRS with 145 mcm laser fiber
SP TFL RIRS with 145 mcm fiber
retrograde intrarenal surgery
SP TFL RIRS with 200 mcm fiber
Superpulse thulium fiber laser RIRS with 200 mcm laser fiber
SP TFL RIRS with 200 mcm fiber
retrograde intrarenal surgery
Ho:YAG RIRS with 200 mcm fiber
Ho:YAG laser RIRS with 200 mcm laser fiber
Ho:YAG RIRS with 200 mcm fiber
retrograde intrarenal surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SP TFL RIRS with 145 mcm fiber
retrograde intrarenal surgery
SP TFL RIRS with 200 mcm fiber
retrograde intrarenal surgery
Ho:YAG RIRS with 200 mcm fiber
retrograde intrarenal surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Radiologically confirmed (CT) kidney stone;
* Stone size from 10 to 20 mm.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.M. Sechenov First Moscow State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dmitry Enikeev, MD, PhD
Deputy director for research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sechenov-RIRS-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.